La Jolla, CA, United States of America

Bochao Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Illumina Corporation. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bochao Zhang. Retrieved from https://idiyas.com/inventor/bochao-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bochao Zhang: Innovator in HLA Diversity Quantification

Introduction

Bochao Zhang is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of immunology through his innovative work. His research focuses on the quantification of HLA diversity, which is crucial for understanding patient responses to therapies.

Latest Patents

Bochao Zhang holds a patent titled "Quantitative score of HLA diversity." This patent provides systems and methods for quantitating the HLA diversity in solid tissue or circulating tumor DNA samples. The technology is predictive of a patient's responsiveness to immune checkpoint inhibitory therapies. He has 1 patent to his name.

Career Highlights

Zhang is currently employed at Illumina Corporation, a leading company in the field of genomics. His work at Illumina has allowed him to contribute to advancements in genetic research and personalized medicine. His expertise in HLA diversity is particularly relevant in the context of cancer treatment.

Collaborations

One of his notable coworkers is Shile Zhang, with whom he collaborates on various research projects. Their combined efforts aim to enhance the understanding of immune responses and improve therapeutic strategies.

Conclusion

Bochao Zhang's innovative work in quantifying HLA diversity represents a significant advancement in immunology. His contributions have the potential to improve patient outcomes in cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…